Golden Valley

GoldenBiotech is a private early-stage biotech and consulting company focused on polymeric drug delivery systems, protein and peptide formulation, combination product/device delivery, and biomaterials. The company appears to be developing proof-of-principle technologies rather than an advanced disclosed clinical pipeline, with expertise spanning sustained and controlled release, PEGylation, in-situ gelation, microparticles, and polymer-based drug depots. Its leadership brings prior experience from Amgen and Ciba-Geigy/Novartis, including work that contributed to marketed products such as Neulasta and a hydrogel contact lens. GoldenBiotech also provides formulation and delivery consulting services through an affiliated consulting business. The company is based in Newbury Park/Thousand Oaks, California and appears to operate as an active private company.